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Apoptosis and autophagy are distinct biological
processes, each driven by a different set of protein-
protein interactions, with significant crosstalk via
direct interactions among apoptotic and autophagic
proteins. To measure the global profile of these inter-
actions, we adapted the Gaussia luciferase protein-
fragment complementation assay (GLuc PCA), which
monitors binding between proteins fused to comple-
mentary fragments of a luciferase reporter. A library
encompassing 63 apoptotic and autophagic proteins
was constructed for the analysis of 3,600 protein-
pair combinations. This generated a detailed land-
scape of the apoptotic and autophagic modules
and points of interface between them, identifying
46 previously unknown interactions. One of these
interactions, between DAPK2, a Ser/Thr kinase
that promotes autophagy, and 14-3-3t, was further
investigated. We mapped the region responsible for
14-3-3t binding and proved that this interaction in-
hibits DAPK2 dimerization and activity. This proof
of concept underscores the power of the GLuc PCA
platform for the discovery of biochemical pathways
within the cell death network.
INTRODUCTION
The life-or-death decision of a cell is a highly complex process by
which multiple prosurvival and prodeath cues are integrated into
a single output that determines the cell’s fate. The main cellular
pathways that mediate these decisions are apoptosis and
autophagy (Rubinstein and Kimchi, 2012). Apoptosis is a pro-
grammed cell death mechanism in which activation of the cas-
pase family of cysteine proteases leads to breakdown of the
cell via the specific cleavage of substrate proteins. Autophagy
is a highly conserved process in which double-membrane vesi-
cles, known as autophagosomes, form to engulf and consume
intracellular content upon fusion with the lysosomes. By recy-
cling macromolecular building blocks and removing damaged
proteins and organelles, autophagy functions as a survivalmechanism, especially during cell stress. Although many of the
proteins driving each of these two basic biological processes
have been discovered over the last few decades, some gaps
may still exist, especially in autophagy, which is a younger field.
Moreover, autophagy and apoptosis are interconnected pro-
cesses. In most cases, autophagy blocks apoptosis progression
by mitigating the cellular damage that triggers cell death (Bhogal
et al., 2012; Kaminskyy et al., 2012; Ravikumar et al., 2006; Su-
zuki et al., 2011) or by directly targeting prodeath proteins for
degradation (Hou et al., 2010; Sandilands et al., 2012a, 2012b).
Conversely, the apoptotic process can actively suppress auto-
phagy by caspase-dependent degradation of major autophagic
proteins to ensure a death response when necessary (Cho et al.,
2009; Luo and Rubinsztein, 2010; Oral et al., 2012; Pagliarini
et al., 2012). Interestingly, in some cellular settings, autophagy
can contribute to cell death by promoting other death pathways
(Basit et al., 2013; Laussmann et al., 2011; Qu et al., 2007; Young
et al., 2012) or, potentially, through overconsumption of critical
cellular survival factors (Nezis et al., 2010; Yu et al., 2006). The
latter type of autophagic cell death can act as a backup mecha-
nism to ensure cell death when caspase-dependent pathways
are blocked (Denton et al., 2012; Shimizu et al., 2004). Based
on this high degree of connectivity, it has been previously sug-
gested that a combined map should be constructed wherein
apoptosis and autophagy constitute two modules within the
overall programmed cell death (PCD) network (Bialik et al., 2010).
The incomplete proteomics landscapes of autophagy and
apoptosis and the growing evidence as to the mechanistic and
therapeutic importance of understanding the crosstalk between
these two distinct PCD modules motivated us to develop new
tools for systematic network analysis. Given that most of the
connectivity between the network’s components involves pro-
tein-protein interactions, we utilized a technology called the pro-
tein-fragment complementation assay (PCA), which enables
detection and analysis of such interactions within cells.
The PCA strategy is based upon the fusion of separate inactive
and structurally unfolded fragments of a reporter protein to two
proteins of interest. When these proteins interact, the fragments
are brought into close proximity and the reporter is folded into its
functional conformation, regaining its activity (Figure S1A). The
PCA strategy was developed and utilized for a variety of applica-
tions using different reporter genes, including the Gaussia
princeps luciferase gene (GLuc) (reviewed in Michnick et al.,Cell Reports 8, 909–921, August 7, 2014 ª2014 The Authors 909
2007). Examples include pathway discovery using cell perturba-
tions and drug actions (MacDonald et al., 2006; Remy and Mich-
nick, 2001; Remy et al., 2004), library screening using GFP PCA
inmammalian cells (Ding et al., 2006; Remy andMichnick, 2004),
systematic large-scale screening of the yeast interactome (Tar-
assov et al., 2008), and systematic measurement of protein con-
centrations (Levy et al., 2014). It was also implemented in the
context of cell death for measuring the dynamics of specific
interactions, such as caspase-2 dimerization (Bouchier-Hayes
et al., 2009) and Bax homodimerization/activation (Yivgi-Ohana
et al., 2011). Here, we utilized the GLuc PCA strategy for a global
unbiased analysis of a large number of protein-protein interac-
tions within the PCD network in mammalian cells. A library
comprising both apoptosis and autophagy proteins was fused
to fragments of GLuc, enabling detection of reversible interac-
tions and quantification of temporal alterations in protein com-
plexes within the cell (Remy and Michnick, 2006). The library
comprised 63 proteins covering a major fraction of the basic
machineries of autophagy and apoptosis and some of their
regulatory proteins. By screening all possible pair combinations,
we identified 46 previously unknown interactions within and be-
tween the autophagy and apoptosis modules, increasing our un-
derstanding of the global organization of the PCD network. One
of these interactions, between DAPK2 and 14-3-3t, was further
analyzed experimentally at the biochemical and cellular levels.
Its discovery provided an important proof of principle of how un-
biased global network analysis can lead to important insights
into the mode of regulation of its individual components; in this
case, a relatively poorly explored death kinase.
RESULTS
Global Screen of the PCD Network
In order to detect protein-protein interactions within the cell
death network, we generated the programmed cell death GLuc
PCA library. The library encompasses 63 proteins, including
apoptosis proteins, autophagy proteins, the death-associated
proteins (DAPs), and proteins previously reported to associate
with and/or regulate apoptotic or autophagic pathways (Table
S1). Since the orientation of the fused luciferase fragments can
have a significant effect on the interaction between some pairs
of proteins and/or on the reconstitution of the luminescence
signal, the majority of the proteins in the library were cloned
in more than one orientation, i.e., GLuc(1)-X, X-GLuc(1), and X-
GLuc(2), where GLuc(1) and GLuc(2) correspond to the N-termi-
nal and C-terminal fragments of the luciferase gene (see Table
S1 and Figure S1B).
The resulting PCD library was screened for all possible
complementation pairs (3,604 combinations using 63 proteins)
in human embryonic kidney 293T (HEK293T) cells. For each
data point, a normalized interaction score (NIS) was calculated
(see Experimental Procedures for details). The screen was per-
formed three times, and the repeats were highly reproducible
(r = 0.93, 0.86, and 0.87; p < 0.0001 for repeats 2 and 3, 1 and
2, and 1 and 3, respectively; see Figure S2). Themean NIS values
calculated from the three experiments, covering the 3,604 inter-
actions, are shown in Table S3. Interactions were considered
positive for mean NIS > 3 and if they were detected in at least910 Cell Reports 8, 909–921, August 7, 2014 ª2014 The Authorstwo out of the three repeats. The results of the screen are dis-
played in Figure 1A as a heatmap, in which NIS values are repre-
sented by a color gradient.
The detected interactions were compared to a manually
curated list of previously reported interactions among these 63
proteins (see Table S2 for a list of 136 published interactions).
Out of a total 131 protein-protein interactions detected in the
screen, 85 were previously reported (representing 62.5% of the
136 known interactions) and 46were not yet identified (Figure 1B;
Table S2). As shown in Figure 2, the GLuc PCA system enabled
the detection of most of the known ‘‘core machinery’’ interac-
tions of the apoptotic and autophagic networks. This includes
interactions between proteins from the death-inducing signaling
complex (DISC), the inhibitors of apoptosis proteins (IAPs), and
the Bcl-2 family in the apoptotic module and interactions within
the ULK1 complex, the Beclin-1/Vps34 complex, and the ubiqui-
tin-like conjugation systems in the autophagic module. Also
several known interactions between autophagic and apoptotic
proteins were detected, such as the Beclin-1-Bcl-2 interaction.
The 46 previously unknown interactions resulting from the
screen are summarized in Table 1. They include two pairs of au-
tophagic proteins, five pairs of apoptotic proteins, nine cross-in-
teractions between apoptotic and autophagic proteins, and 13
interactions between the DAP proteins and components of the
autophagic or apoptotic machinery. Additionally, the screen ex-
tends the list of proteins interacting with the two scaffold pro-
teins, p62 and FADD, beyond the current published information
(11 and 5 interactions, respectively). Detailed examination of the
NIS values within the group of known interactions revealed that
although some of the proteins in the library are components of
larger multiprotein complexes, the system is specific for direct
interactions between pairs of proteins and does not detect indi-
rect interactions between proteins from the same complex. For
example, UVRAG and Atg14 are both part of the autophagic
Beclin-1/Vps34 complex, each interacting directly with Beclin-
1 (Itakura et al., 2008). Both proteins exhibited high NIS values
for complementation with Beclin-1 (379.36 and 402.61, respec-
tively; Table S3), but not with each other (Table S3). Another
example relates to the interaction of Atg16 with the Atg12-Atg5
conjugate. Atg12 and Atg5 are covalently linked in cells by a
highly conserved ubiquitin-like conjugation system. The Atg12-
Atg5 conjugate associates with Atg16, and this interaction
occurs via direct binding to Atg5 (Matsushita et al., 2007). The
Atg5/Atg16 interaction was detected in our screen, whereas
the indirect interaction between Atg12 and Atg16 yielded a
below-threshold complementation value. This means that the
additional positive hits may reflect direct protein-protein interac-
tions, although we cannot exclude the possibility that in some
protein complexes the luciferase fragments may be oriented
close enough in space to fold even if the interaction is indirect,
as previously reported (Tarassov et al., 2008).
Validation of GLuc PCA Reporters for Known Protein-
Protein Interactions: Follow-up of Specificity,
Reversibility, and the Dynamics of the
Luminescent Signal
In order to demonstrate that the luciferase signal truly represents
the state of the detected interactions and that the positive GLuc
Figure 1. PCA Screen in HEK293T Cells
(A) Heatmap showing mean NIS values of the three screen repeats between individual pairs of GLuc(1) (rows) and GLuc(2) (columns) fusion proteins within the
library.
(B) Venn diagram of the interactions detected in the PCA screen versus previously known interactions.
(C) Histogram representing the distribution of NIS values across the library. The number of samples was plotted as a function of log2 of NIS values.
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Figure 2. Network View of all the Detected Protein-Protein Interactions in the GLuc PCA Screen
The nodes are colored according to their pathway association: apoptotic genes (red), autophagic genes (blue), DAP genes (purple), and proteins that were
reported to associate and regulate the apoptotic and autophagic modules (gray). Edges represent positive interactions detected in theGLuc PCA screen (NIS > 3)
in at least two out of the three repeats. Previously reported interactions are represented by black edges, and additional interactions detected in the screen are
represented by red edges.PCA pairs can be used as reporters for specific protein-protein
interactions, we performed several validation experiments by
manipulating known protein interactions and testing their effect
on the luminescence signal, either by applying cellular stress
or by introducing inhibitory point mutations. The first to be tested
was the GLuc PCA reporter of a well-defined pair of interacting
proteins from the apoptotic module, the endonuclease CAD
and its inhibitor ICAD. Apoptosis induction results in caspase-
3-mediated cleavage of ICAD and the release of CAD, leading
to the characteristic internucleosomal DNA cleavage (Nagata,
2000). Coexpression of ICAD and CAD fused to the Gluc(1)
and GLuc(2) fragments resulted in high complementation signals
(Table S3). Upon treatment with the apoptotic trigger stauro-
sporine (STS), a gradual decrease in the luciferase signal was
observed over time (Figure 3A), which inversely correlated with
increased ICAD cleavage as detected by western blotting of
the cell lysates (Figure 3B), indicating the reversibility of the
ICAD-CAD GLuc PCA. Notably, addition of the pan-caspase
inhibitor QVD-OPH prevented caspase-mediated cleavage of912 Cell Reports 8, 909–921, August 7, 2014 ª2014 The AuthorsICAD and attenuated the decrease in luminescence (Figures
3A and 3B). Importantly, both endogenous and luciferase-fused
ICAD responded to STS with similar temporal kinetics (Fig-
ure 3B), indicating that the addition of the luciferase fragment
did not change the sensitivity of the ICAD protein to caspase
cleavage.
Assessment of the Atg12/Atg5 interaction provided an addi-
tional validation strategy, based on the knowledge that the
conjugation between these two proteins depends on the C-ter-
minal glycine of Atg12 and therefore might be inhibited by
fusing the luciferase fragment to the C terminus. Indeed,
whereas coexpression of GLuc(1)-Atg12 with Atg5-GLuc(2) re-
sulted in a positive NIS value (5.75), coexpression of Atg12-
GLuc(1) and Atg5-GLuc(2) resulted in a signal below the
threshold (Table S3). To further verify this result, we coexpressed
both GLuc(1)-Atg12 and Atg12-GLuc(1) with Atg5-GLuc(2) and
analyzed the cell lysates for both luminescence and western
blotting (Figures 3C and 3D). As expected, the exogenous
Atg5-Atg12 conjugate was detected by western blot only in the
Table 1. Previously Unknown Interactions Detected in the
Programmed Cell Death GLuc PCA Screen
No. Protein A Protein B Repeats No. Protein A Protein B Repeats
1 Ambra1 Casp8 3 24 DAPK3 FADD 3
2 Ambra1 P62 3 25 DAPK3 DAPK2 3
3 Ambra1 BAG3 3 26 DAPK3 cFLIP 3
4 Ambra1 PIDD 2 27 FADD Bcl-Xl 3
5 Atg14 DAPK2 3 28 FADD CytC 3
6 Atg14 P62 2 29 FADD LC8 3
7 Atg4B DAPK2 2 30 LIVIN DAP1 2
8 Atg4B LC8 2 31 Mcl-1 FADD 3
9 Atg9 WIPI2 2 32 P62 FADD 3
10 Bcl-2 P62 2 33 P62 LC8 3
11 Beclin-1 P62 3 34 P62 CAD 2
12 BID BAD 2 35 P62 DAPK2 2
13 BID FADD 3 36 PGAM5 Bcl-2 2
14 Bnip3L Bax 3 37 Smac CytC 2
15 Casp8 PIDD 2 38 Smac DAP1 2
16 cFLIP P62 3 39 Survivin Atg12 2
17 CytC Casp8 3 40 TRADD P62 3
18 DAP1 BID 3 41 WIPI2 XIAP 3
19 DAP1 BAD 2 42 WIPI2 Casp8 3
20 DAP1 FADD 2 43 WIPI2 ULK1 3
21 DAPK2 14-3-3 3 44 WIPI2 P62 3
22 DAPK2 CytC 2 45 WIPI2 LIVIN 2
23 DAPK3 BAD 3 46 WIPI2 PIDD 2
Interactions were considered positive for mean NIS > 3 and if they were
detected in at least two out of the three repeats.GLuc(1)-Atg12+Atg5-GLuc(2) sample, correlating with the PCA
signal, which was 12-fold higher. Thus, the GLuc(1)-Atg12-
Atg5-GLuc(2) PCA reporter truly represents the state of the con-
jugate in cells.
Another validation was performed with the antiapoptotic pro-
tein Mcl-1. Expression of wild-type Mcl-1 resulted in high NIS
values with the proapoptotic proteins Bax and Bak. In contrast,
insertion of a single mutation within the BH3 binding pocket of
Mcl-1 (R263A), previously shown to ablate Mcl-1 binding to pro-
apoptotic proteins (Meng et al., 2007), strongly decreased the
luminescence signals, further confirming the specificity of the
system (Figure 3E).
Taken together, these validations demonstrate that the
different GLuc PCA pairs detected in the screen truly represent
the state of different protein-protein interactions and can be
further utilized as sensitive and quantitative probes for these
interactions.
Previously Unidentified Interactions Detected in the
GLuc PCA Screen
Among the interactionsdetected in the screen (seeTable 1), an in-
teracting partner for the autophagy-regulating kinase ULK1 was
identified. As shown in Figure 4A, the GLuc PCA screen detected
the known interaction betweenULK1 andAtg13, amember of the
ULK complex that interacts directly with ULK1 and is essential forautophagosome formation (Hosokawa et al., 2009). In addition,
interactions between ULK1 and two members of the Beclin1/
Vps34 complex, UVRAG and Atg14, were detected. These
interactions have recently been described as essential for
ULK1-mediated phosphorylation of Beclin-1, as Atg14 and
UVRAG serve as adaptors that enable ULK1 association with
the Beclin-1/Vps34 complex (Russell et al., 2013). Consistent
with these results, the GLuc PCA screen did not detect any direct
binding between ULK1 and Beclin-1. Interestingly, an interaction
between ULK1 and WIPI2 was also detected (Figure 4A). WIPI2,
an effector of Ptdins3P, is required for LC3 lipidation and for the
maturationof omegasomestructuresandwasshownbycoimmu-
nostaining to be recruited to the preautophagosomal structure
and to bind Atg16L (Polson et al., 2010). Validation of this interac-
tion by coimmunoprecipitation showed that ectopically ex-
pressed FLAG-ULK1 pulled down WIPI2 fused to hemagglutinin
(HA) from cells (Figure 4B). Thus, the direct interaction between
ULK1 andWIPI2 thatwas revealed by the PCA screenmay reflect
a previously unknown mechanistic function of ULK1.
The screen also detected a recently reported interaction be-
tween ULK1 and Ambra1, which is phosphorylated by ULK1,
causing its release from dynein light chain (LC8), an essential
step for autophagy induction (Di Bartolomeo et al., 2010). In
addition, Ambra1 GLuc PCA (Figure 4C) resulted in positive
complementation values with Beclin-1 and LC8, confirming
these two previously reported interactions (Di Bartolomeo
et al., 2010; Fimia et al., 2007). Among the previously unknown
interactions, Ambra1 was observed to interact with the proapo-
ptotic proteins caspase-8 and PIDD, providing interesting points
of interface between apoptotic and autophagic proteins.
Notably, the molecular chaperone BAG3, an antiapoptotic pro-
tein that interacts with Bcl-2 and also mediates selective auto-
phagy of misfolded proteins by binding to p62 (Gamerdinger
et al., 2009), was also identified as an Ambra-1 partner. These
interactions reveal additional links between Ambra1 and
different components of the cell death network (Figure 4C) and
may provide clues for its molecular function.
Interestingly, among the different proteins in the library, the
Bcl-2 family was found to be highly compatible with the GLuc
PCA system, as the screen detected most of the interactions
among the family members with relatively high NIS values (Fig-
ures 4D and 4E). Moreover, the different antiapoptotic Bcl-2
members showed differential BH3-only binding profiles that
correspond to previous analysis of this protein family (Chen
et al., 2005). For example, while Bcl-2, Bcl-XL, and Bcl-W had
high complementation signals with the BH3-only protein BAD,
Mcl-1 complementation with BADwas below background. Inter-
estingly, we discovered an interaction between Bax and Bnip3L
(Figures 4D and 4E). Bnip3L (Bnip3-like, also known as NIX) and
the closely related Bnip3 are BH3-only-like proteins that play
similar roles in both autophagy and cell death (Yasuda et al.,
1998; Zhang and Ney, 2009). Genetically, Bax and Bak were
shown to be required for Bnip3-induced mitochondrial dysfunc-
tion and cell death in mouse embryonic fibroblasts (Kubli et al.,
2007). The GLuc PCA screen now shows a direct physical inter-
action between Bnip3L and Bax, thus providing an additional
direction for investigation into the mechanism of Bnip3L-medi-
ated cell death.Cell Reports 8, 909–921, August 7, 2014 ª2014 The Authors 913
Figure 3. Validation of GLuc PCA Reporters Using Cellular Stress and Mutagenesis
(A) ICAD-GLuc(1) and CAD-GLuc(2) were expressed in HeLa cells in the presence or absence (NT) of staurosporine (2 mM, STS) at the indicated time points, with
or without QVD-OPH (50 mM), a pan-caspase inhibitor, and the GLuc PCA signal was measured in cell lysates.
(B) Western blotting of the corresponding cell lysates shown in (B) for the indicated proteins usingGaussia luciferase, iCAD, and tubulin antibodies. The upper and
lower ICAD fragments result from cleavage of ICAD-GLuc(1) and endogenous ICAD, respectively.
(C) Relative luminescence signal (RLU) as measured by coexpression of the different Atg12 and Atg5 GLuc PCA plasmids.
(D) HEK293T cells were transfected with different combinations of GLuc(1)-Atg12, Atg12-GLuc(1), and Atg5-GLuc(2), and western blotting was performed using
Atg5 and Atg12 antibodies, showing the expression levels of each of the proteins and the generation of the GLuc(1)-Atg12-Atg5-GLuc(2) conjugate
(marked with *).
(E) Wild-type MCL1-GLuc(1) and MCL1(R263A)-GLuc(1) were coexpressed with Bax-GLuc(2) or Bak-GLuc(2), and the luminescence signal was measured from
cell lysates after 24 hr. The results are displayed as mean ± SD of RLU from three independent repeats. *p < 0.05, **p < 0.01, and ***p < 0.001 (Student’s t test).Focusing on the DAPK2/14-3-3t Interaction:
DAPK2 Interacts with 14-3-3t via a Ser/Thr-Rich Stretch
Mapped to the Former’s C Terminus
One of the benefits of the current GLuc PCA library was that it
enabled unbiased analysis of the direct interacting proteins of
little known proteins previously shown to regulate apoptosis
and/or autophagy. One of these candidates is DAPK2 (death-
associated protein kinase 2, also named DRP-1), a Ca2+/
calmodulin-regulated serine/threonine kinase (Figure 5B) that
belongs to the DAP-kinase family of proteins, which function
as positive mediators of apoptosis and autophagy (Bialik and
Kimchi, 2006; Eisenberg-Lerner and Kimchi, 2012; Inbal et al.,
2000, 2002; Shiloh et al., 2014; Zalckvar et al., 2009). Very little914 Cell Reports 8, 909–921, August 7, 2014 ª2014 The Authorsis known on DAPK2’s mode of activation and biochemical func-
tion. The GLuc PCA screen identified six DAPK2-interacting
proteins (Figure 5A), five of which were also validated by coim-
munoprecipitation experiments (see Figure S3 for Atg4B,
Atg14, DAPK3, and p62 and Figures 5D and 5E for 14-3-3t).
The interaction between DAPK2 and 14-3-3twas further studied
here in detail. 14-3-3t is a member of the highly conserved 14-3-
3 family of proteins, which, by preferentially binding specific
consensus motifs within phospho-Ser-containing proteins (Liu
et al., 1997; Muslin et al., 1996; Yaffe et al., 1997), play important
roles in the regulation of diverse biological processes, including
cell growth control, neuronal development, apoptosis, and auto-
phagy (Fu et al., 2000; Pozuelo-Rubio, 2011).
Figure 4. ULK1, Ambra1, and the Bcl-2 Family Subnetworks
(A) ULK1-interacting proteins as detected in the screen. Known interactions are colored in blue and previously unknown interactions in red.
(B) Coimmunoprecipitation of FLAG-tagged ULK1 with HA-tagged WIPI2 from HEK293T cells.
(C) Ambra1-interacting proteins as detected in the screen.
(D) Bcl-2 family subnetwork.
(E) Heatmap representing NIS values of various combinations of Bcl-2 family members.In order to validate the PCA interaction, we performed coim-
munoprecipitation experiments in which either 14-3-3-FLAG or
FLAG-DAPK2 pulled down HA-DAPK2 or 14-3-3-HA, respec-
tively (Figures 5D and 5E). FLAG-DAPK2 also interacted with
endogenous 14-3-3t (Figure S4). To check whether other 14-
3-3 isoforms bind DAPK2, FLAG-DAPK2 was immunoprecipi-
tated from 293T cells and resolved by SDS-PAGE. Two bands
at the predicted size of 14-3-3t (28 kDa) were analyzed by
mass spectrometry and identified at high confidence as the
theta and epsilon isoforms of 14-3-3 (Figure 5F), suggesting
that either DAPK2 binding is not restricted to a specific 14-3-
3 isoform or that a heterodimer of the two isoforms binds
DAPK2 within cells.
Examination of DAPK2’s amino acid sequence identified a
serine-rich motif at its C terminus that potentially matches a
14-3-3 binding site (RX1-2SX2-3S) (Figure 5C) (Liu et al., 1997).
Notably, the 14-3-3-GLuc(2) interaction with GLuc(1)-DAPK2
resulted in a much higher complementation signal than with
DAPK2-GLuc(1), consistent with the C-terminal fusion blocking
the binding site (Figure S5). Given that 14-3-3 proteins usuallybind phosphorylated proteins, we searched the PhosphoSite-
Plus (http://www.phosphosite.org) database for detected phos-
phorylation of the DAPK2 protein and found that C-terminal
S367, S368, T369, and S370 are phosphorylated in both human
and mouse orthologs. A mutant lacking the last five amino acids
of the protein (DAPK2D5) was generated and tested using the
GLuc PCA system (Figure 5G). Significantly, while coexpression
of GLuc(1)-DAPK2 and 14-3-3-GLuc(2) resulted in a high
complementation of the luciferase fragments, the D5 mutation
almost completely abolished the signal. Loss of 14-3-3 binding
was also observed upon coimmunoprecipitation of FLAG-
DAPK2D5 (Figure 5F), suggesting that the C-terminal tail of
DAPK2 is indeed essential for its interaction with 14-3-3t. To
examine the phosphorylation status of these Ser/Thr residues
in HEK293 cells at basal growth conditions, we used an
antibody targeted against the RXRXXpS/T consensus sequence.
This antibody recognized immunoprecipitated wild-type (WT)
FLAG-DAPK2, but not FLAG-DAPK2 D5 (Figure 5I). Moreover,
pretreatment of cell extracts with l phosphatase eliminated the
signal, confirming that the Abs indeed recognize phosphorylatedCell Reports 8, 909–921, August 7, 2014 ª2014 The Authors 915
Figure 5. DAPK2 Interacts with 14-3-3t
(A) DAPK2-interacting proteins as detected in the PCA screen.
(B) Schematic of domain organization of DAPK2.
(C) Amino acid sequence of DAPK2. The 14-3-3 binding sequence is colored in red.
(D) Coimmunoprecipitation of FLAG-tagged DAPK2 with HA-tagged 14-3-3t from HEK293T cells.
(E) Reciprocal coimmunoprecipitation of FLAG-tagged 14-3-3t with HA-tagged DAPK2 from HEK293T cells.
(F) Immunoprecipitation of FLAG-DAPK2 and FLAG-DAPK2D5 from HEK293T cells. Samples were subjected to SDS-PAGE and gel stained with Gelcode
reagent. Arrows indicate endogenous 14-3-3 isoforms t and ε, as detected by mass spectrometry.
(G) GLuc(1)-DAPK2 and 14-3-3-GLuc(2) PCA. The different DAPK2 mutants were cotransfected into HEK293T cells with 14-3-3-GLuc(2). Relative luminescence
was measured after 24 hr in the cell lysates as indicated. ***p < 0.001 (Student’s t test).
(H) Western blot of samples from (G) were blotted using Gaussia luciferase antibody, which recognizes both luciferase fragments.
(I) FLAG tagged DAPK2 or FLAG-DAPK2D5 were immunoprecipitated from HEK293T cells and blotted with RXRXXpS/T and DAPK2 antibodies.
(J) Immunoprecipitated FLAG-DAPK2 was incubated with or without l phosphatase for 30 min at 37C and blotted with RXRXXpS/T and DAPK2 antibodies.residues in DAPK2’s C terminus and that these residues
are phosphorylated at basal growth conditions (Figure 5J). Addi-
tional point mutations of the suspected Ser residues indicated a
reduced complementation signal between 14-3-3-GLuc(2) and
GLuc(1)-DAPK2(S367A), GLuc(1)-DAPK2(S368A), or GLuc(1)-916 Cell Reports 8, 909–921, August 7, 2014 ª2014 The AuthorsDAPK2(T369A), suggesting a partial role for each of these
residues in 14-3-3 binding (Figure 5G). In contrast, the
GLuc(1)-DAPK2(S370A) mutation had no effect on the interac-
tion. Importantly, the WT and mutant proteins were expressed
at comparable levels in these experiments (Figure 5H).
Measuring the Functional Outcome of the Interaction:
14-3-3t Inhibits DAPK2’s Activity Both in Cells and in
Cell-free Systems
Overexpression of DAPK2was previously shown to cause exten-
sive membrane blebbing, leading to detachment from extracel-
lular matrix and cell death (Shani et al., 2001). FLAG-DAPK2D5
was slightly more active than FLAG-DAPK2 in inducing mem-
brane blebbing upon overexpression in HEK293T cells. Signifi-
cantly, coexpression of 14-3-3 strongly inhibited the blebbing
phenotype induced by FLAG-DAPK2, but not FLAG-DAPK2D5,
which cannot bind 14-3-3 (Figures 6A and 6B). Western blot
analysis verified that the differences were not due to differential
expression of the DAPK2 constructs (Figure 6C).
In order to test the effect of 14-3-3 on DAPK2’s kinase activity
in vitro, an ELISA kinase assay using myosin II regulatory light
chain (MLC) as an exogenous substrate was performed. FLAG-
DAPK2 was incubated with recombinant MLC in the presence
of increasing amounts of 14-3-3, and phosphorylation levels
were quantified using a phospho-Ser19-MLC antibody. Consis-
tent with the in vivo data, the presence of 14-3-3 significantly
reduced DAPK2 activity in vitro in a dose-dependent manner
(Figures 6D and 6E).
The 40-amino-acid tail of DAPK2 was previously shown to be
required for its homodimerization (Shani et al., 2001). To deter-
mine whether 14-3-3t inhibits DAPK2 activity by preventing its
dimerization, we conducted a competition assay by overex-
pressing GLuc(1)-DAPK2 and DAPK2-GLuc(2) with increasing
levels of 14-3-3-FLAG. The ICAD-GLuc(1) and CAD-GLuc(2)
PCA pair was used as a negative control. The presence of
14-3-3t decreased the dimerization signal of DAPK2 by more
than 50% but had no effect on the ICAD-CAD interaction (Fig-
ure 6F), suggesting that 14-3-3 binding to the DAPK2 C termi-
nus prevents its homodimerization, thereby reducing its kinase
activity.
DISCUSSION
In this work, we constructed the PCD-GLuc PCA library and pre-
sented the outcome of an unbiased screen that examined all
possible interactions between the individual library components.
We found that the library enables rapid and accurate detection of
protein-protein interactions and quantitative analysis of specific
interactions in detail. The use of a large interaction data set
enabled normalization of the complementation readouts, a sta-
tistically accurate method to distinguish real hits from nonspe-
cific noise. The high specificity of the complementation signals
was confirmed by introducing critical point mutations that abol-
ished both the physical interactions and the luminescent signals
(e.g., mutations of Mcl-1, and DAPK2) and by examination of the
response of specific pair of proteins to cellular stress (e.g., the
ICAD-CAD reporter). Furthermore, the system was sensitive
enough to detect quantitative differences in the interaction pro-
files of members of a protein family of similar size and structure.
For example, the normalized complementation signals of Atg4B
with LC3 and GABARAPL2 were much higher than those of the
highly related Atg4A (349.01 versus 19.24 and 89.98 versus a
below-threshold signal, respectively; see Table S3), consistent
with previous observations that recognized Atg4B as the mostactive member of the Atg4 family (Li et al., 2011). Thus, the
GLuc PCA system can be utilized to uncover quantitative differ-
ences in the protein-protein interaction profile within family
members that share structural similarities and equal levels of
the ectopically expressed luciferase-fused proteins.
We show here that the PCD-GLuc PCA screen can be used to
study most ‘‘core-machinery’’ interactions in the apoptotic and
autophagic networks. Furthermore, and most importantly, previ-
ously unknown interactions were detected that can be analyzed
further, as was done for DAPK2/14-3-3t, thereby contributing to
our understanding of these important pathways and the cross-
talk between them. For example, the ULK1 interaction with
WIPI2 detected here can close some existing gaps in the auto-
phagic module. The connectivity of caspase-8 to Ambra-1 and
WIPI2 indicates that these two autophagic proteins may be
cleaved by caspase-8, thus adding additional points of interface
between apoptosis and autophagy. The autophagy field is
rapidly expanding, and recent functional screens have revealed
a growing number of autophagy-related proteins (McKnight
et al., 2012; Orvedahl et al., 2011; Szyniarowski et al., 2011).
The GLuc PCA system can facilitate the annotation of these
newly discovered genes by discovery of specific interactions
with the core autophagy machinery. The introduction of the
DAP proteins into the current GLuc PCA library is a good
example of this conceptual approach. Several interactions of
DAPK1, DAPK2, and DAPK3 with components of autophagy
and apoptosis core machineries that were discovered here can
be studied in depth in the future (Table 1). Notably, for DAPK2,
we validated by coimmunoprecipitation studies five out of the
six GLuc PCA interactions, further supporting the high reliability
of the GLuc PCA screen. Extension of the existing library to
additional missing or yet-to-be-discovered genes will further in-
crease the landscape of interactions.
Overall, the screen missed 37.5% of the previously known in-
teractions. This may emerge from possible conformation
changes of some of the library proteins caused by the fusion to
the luciferase fragments or the inability to reconstitute functional
luciferase due to some steric hindrance. Also, transient interac-
tions, such as kinase-substrate and caspase-substrate interac-
tions, may be missed due to the reversible nature of the GLuc
PCA. In addition, the GLuc PCA screen presented in this work
was performed under basal growth conditions without applying
external stress or stimuli. Although overexpression may be suffi-
cient to activate certain apoptotic proteins (e.g., caspases),
other genes may require signaling cues and posttranslational
modifications for their full activation, and therefore some interac-
tions may have been missed. Thus, it will be informative to also
examine the dynamics of the interaction map in response to
different biological stimuli and perturbations.
The GLuc PCA reporters described in this work can be used as
a framework for a variety of applications, such as drug screening.
For example, the Bcl-2 family GLuc PCA reporters can be utilized
for amore quantitative understanding of the differential effects of
BH3-mimetic drugs, which are used for cancer treatment (van
Delft et al., 2006), on specific protein-protein interactions within
the Bcl-2 family. The system can also be used for screening in-
hibitors of specific protein interactions to target particular protein
complexes within the apoptosis or autophagy modules.Cell Reports 8, 909–921, August 7, 2014 ª2014 The Authors 917
Figure 6. 14-3-3t Inhibits DAPK2Hs Activity
(A) 293T cells were transfected with GFP and 14-3-3-FLAG, FLAG-DAPK2, or FLAG-DAPK2D5 in various combinations and imaged after 24 hr. Arrows indicate
examples of blebbed cells.
(B) Quantification of the extent of blebbing among GFP-positive cells as mean ± SD of three independent repeats.
(C) Western blot of a representative experiment from (A).
(D) Purified DAPK2 was incubated with MLC in an in vitro kinase assay in the presence of purified 14-3-3t, in various molar ratios, and phosphorylated MLC was
quantitated by ELISA assay with phospho-MLC antibodies.
(E) Mean kinase activity ± SD (n = 6) of purified DAPK2 with or without 14-3-3 (at the 1:2 molar concentrations) toward nonlimiting amounts of MLC (1 mg) as
measured by the quantitative ELISA assay described in (D).
(F) GLuc(1)-DAPK2 and DAPK2-GLuc(2) or ICAD-GLuc(1) and CAD-GLuc(2) were expressed alone or in the presence of 2 or 4 mg 14-3-3-FLAG plasmid. Twenty-
four hours later, the cells were lysed and luminescence was monitored. Complementation levels of each pair in the absence of 14-3-3t were set as 100%.
**p < 0.01 and ***p < 0.001 (Student’s t test).Finally, it should be stressed that by discovering the inhibitory
effect of 14-3-3 on DAPK2’s activity, a mode of regulation of the
kinasewas identified. This is a third layer of regulation (Figure S6),918 Cell Reports 8, 909–921, August 7, 2014 ª2014 The Authorsin addition to previously demonstrated regulations by an
autoinhibitory phosphorylation on Ser308 and by Ca2+/CaM
binding (Shani et al., 2001). These multiple layers of regulation
emphasize the importance of controlling the activity of this
death-associated kinase to restrict its harmful effects at basal
growth conditions. Interestingly, the 14-3-3 binding is mediated
by DAPK2’s C terminus, which is not shared by other members
of the DAPK family. Downregulation of DAPK expression due
to promoter hypermethylation is believed to contribute to the
progression of many cancers (Bialik and Kimchi, 2006). DAPK2
has also been shown to be downregulated by hypermethylation
in leukemia (Tur et al., 2009). Functional inhibition of the ex-
pressed protein by binding to 14-3-3 may provide a second
mechanism for silencing DAPK2 to promote cancer develop-
ment and evasion of cell death. Indeed, different isoforms of
14-3-3 have been found to be upregulated in cancer and are
recognized as poor-prognosis markers. Thus, the interaction be-
tween DAPK2 and 14-3-3 can be a potential target for cancer
treatment. Additional work is required to elucidate the physiolog-
ical role of the interaction between DAPK2 and 14-3-3, to study
its dynamics in response to different stimuli, and to identify the
kinase that phosphorylates DAPK2 on its C terminus. The
GLuc PCA reporters described in this work can be utilized to
address these issues.
EXPERIMENTAL PROCEDURES
Bioluminescence Assay and Analysis
HeLa or HEK293T cells were reverse transfected in white 96-well tissue culture
plates (BD Falcon) coated with 25 ng of each PCA plasmid in the presence of
150 mM NaCl containing 0.5 ml JetPEI reagent. Twenty-four hours later, the
cells were lysed in luciferase lysis buffer (25 mM Tris [pH 8.5], 150 mM NaBr,
5mMEDTA, 0.1%NP40, 5%glycerol, 65 mMsodium oxalate, 0.5mM reduced
glutathione, and 0.5 mM oxidized glutathione). Native coelenterazine (Nano-
light) was diluted in luciferase assay buffer (25 mM Tris [pH 7.75], 1 mM
EDTA, 0.5 mM reduced glutathione, 0.5 mM oxidized glutathione, and
75mMurea) to a final concentration of 20 mM. Luminescence signal (integrated
over 10 s) was read using a Veritas microplate luminometer (Turner Bio-
Systems). Variations in background signal of the different proteins in the library
were detected, whichmay result from differences in expression levels, a higher
tendency of some proteins to interact nonspecifically with other proteins
(‘‘stickiness level’’), basal affinity to the luciferase fragments, and allosteric
constrains due to variance in protein size or structure. In order to avoid such
false readouts, each data point was given a normalized value (NIS) calculated
by dividing the luminescence readout for each pair of proteins (A + B) by the
sum of the median complementation values of each of the proteins over the
entire set: NIS= ðA+B complementationÞ=½Median A+ ½Median B.
ELISA Kinase Assay
The 96-well ELISA maxiSorp plates (Nunc) were coated with various amounts
of recombinant human MLC (purified from E. coli) and incubated at 4C for
72 hr. The plate wells were washed and blocked with 100 ml blocking solution
(4% BSA, 0.02% azide in PBS) for 1 hr at 37C. FLAG-DAPK2 and 14-3-3-
FLAG, which were immunopurified from HEK293T cells, were preincubated
in various amounts in protein kinase buffer (NEB) with 10 mM ATP and added
to the ELISA plate for 20min. The reaction was stoppedwith 28mMEDTA. The
wells were then incubated with pSer19 MLC primary antibody (Cell Signaling),
followed by horseradish peroxidase-conjugated goat anti-rabbit secondary
antibody, and fresh ABTS substrate solution (28 mM mM citric acid, 22 mM
Na2HPO4, 0.006%H2O2, and 1.8mMABTS), and the color reaction was quan-
tified using an ELISA plate reader.
Blebbing Assay
HEK293T cells were transfected with GFP, FLAG-DAPK2, or FLAG-DAPK2D5
either with or without 14-3-3-FLAG. Twenty-four hours later, the cells were
imaged by fluorescence microscopy (Olympus BX41) and the blebbed cellswere counted. The cells were then harvested and lysed for western blot anal-
ysis in order to verify equal expressions of the DNA constructs.
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